(Q35582622)

9 August 2017

1 reference

title

Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease (English)

1 reference

Cardiology and cardiovascular medicine

9 August 2017

0 references

1 reference

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00965-2

1 April 2024

3

Neal S Kleiman

1 reference

9 August 2017

Cindy Grines

1

1 reference

9 August 2017

Pran Marrott

series ordinal

4

1 reference

9 August 2017

Gabor M. Rubanyi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615023

1 April 2024

Matthew W. Watkins

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615023

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

7 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14615023

full work available at URL

1 April 2024

https://api.elsevier.com/content/article/PII:S0002914903009652?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00965-2

https://api.elsevier.com/content/article/PII:S0002914903009652?httpAccept=text/plain

1 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00965-2

American Journal of Cardiology

1 April 2024

published in

1 reference

9 August 2017

volume

92

1 reference

9 August 2017

issue

9B

1 reference

9 August 2017

page(s)

24N-31N

1 reference

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Cardiovascular gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Receptors mediating adenovirus attachment and internalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Coronary collateral development in swine after coronary artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900965-2

7 January 2021

Identifiers

1 reference

9 August 2017

1 reference